Recommendations on screening for breast cancer in women aged 40–74 years who are not at increased risk for breast cancer

[See related article at [www.cmaj.ca/lookup/doi/10.1503/cmaj.181538][2]][2] KEY POINTS Breast cancer mortality rates among Canadian women have declined from 41.7 per 100 000 in 1988 to an estimated 23.2 per 100 000 in 2017, while age-standardized incidence has remained relatively stable, at around

[1]  Robert T. Fazzio,et al.  Breast Cancer Screening for Women at Average Risk , 2019, Current Breast Cancer Reports.

[2]  S. Driedger,et al.  Can you un-ring the bell? A qualitative study of how affect influences cancer screening decisions , 2017, BMC Cancer.

[3]  R. Grad,et al.  Shared decision making in preventive health care: What it is; what it is not. , 2017, Canadian family physician Medecin de famille canadien.

[4]  Mohammed T Ansari,et al.  The GRADE Working Group clarifies the construct of certainty of evidence. , 2017, Journal of clinical epidemiology.

[5]  X. Castells,et al.  A qualitative study on a decision aid for breast cancer screening: Views from women and health professionals , 2017, European journal of cancer care.

[6]  E. Paci,et al.  Advanced breast cancer rates in the epoch of service screening: The 400,000 women cohort study from Italy. , 2017, European journal of cancer.

[7]  Elena B. Elkin,et al.  Facilitating informed decisions about breast cancer screening: development and evaluation of a web-based decision aid for women in their 40s , 2017, BMC Medical Informatics and Decision Making.

[8]  L. Nyström,et al.  Reduced breast cancer mortality after 20+ years of follow-up in the Swedish randomized controlled mammography trials in Malmö, Stockholm, and Göteborg , 2017, Journal of medical screening.

[9]  R. Luckmann,et al.  Persuasive Interventions for Controversial Cancer Screening Recommendations: Testing a Novel Approach to Help Patients Make Evidence-Based Decisions , 2017, The Annals of Family Medicine.

[10]  Laura A. Gibson,et al.  Effects of a risk-based online mammography intervention on accuracy of perceived risk and mammography intentions. , 2016, Patient education and counseling.

[11]  T. To,et al.  Revised estimates of overdiagnosis from the Canadian National Breast Screening Study. , 2016, Preventive medicine.

[12]  V. Kristensen,et al.  Women at high risk of breast cancer: Molecular characteristics, clinical presentation and management. , 2016, Breast.

[13]  Rochelle Fu,et al.  Effectiveness of Breast Cancer Screening: Systematic Review and Meta-analysis to Update the 2009 U.S. Preventive Services Task Force Recommendation , 2016, Annals of Internal Medicine.

[14]  Evelyn P Whitlock,et al.  Supplemental Screening for Breast Cancer in Women With Dense Breasts: A Systematic Review for the U.S. Preventive Services Task Force , 2016, Annals of Internal Medicine.

[15]  T. Wilt,et al.  Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation Statement , 2011 .

[16]  F. Chauvin,et al.  Decision aid on breast cancer screening reduces attendance rate: results of a large-scale, randomized, controlled study by the DECIDEO group , 2016, Oncotarget.

[17]  O. Razum,et al.  Informed Choice in the German Mammography Screening Program by Education and Migrant Status: Survey among First-Time Invitees , 2015, PloS one.

[18]  J. Lortet-Tieulent,et al.  Breast Cancer Screening for Women at Average Risk: 2015 Guideline Update From the American Cancer Society. , 2015, JAMA.

[19]  E. Benítez-Rodríguez,et al.  Using an informed consent in mammography screening: a randomized trial , 2015, Cancer medicine.

[20]  Preconceptions influence women’s perceptions of information on breast cancer screening: a qualitative study , 2015, BMC Research Notes.

[21]  S. Duffy,et al.  Effect of mammographic screening from age 40 years on breast cancer mortality in the UK Age trial at 17 years' follow-up: a randomised controlled trial. , 2015, The Lancet. Oncology.

[22]  B. Cowling,et al.  Towards informed decisions on breast cancer screening: Development and pilot testing of a decision aid for Chinese women. , 2015, Patient education and counseling.

[23]  Rocio Garcia-Retamero,et al.  Understanding the Harms and Benefits of Cancer Screening , 2015, Medical decision making : an international journal of the Society for Medical Decision Making.

[24]  L. Irwig,et al.  Use of a decision aid including information on overdetection to support informed choice about breast cancer screening: a randomised controlled trial , 2015, The Lancet.

[25]  P. Hewitson,et al.  People’s willingness to accept overdetection in cancer screening: population survey , 2015, BMJ : British Medical Journal.

[26]  M. Pentzek,et al.  Willingness to participate in mammography screening: a randomized controlled questionnaire study of responses to two patient information leaflets with different factual content. , 2015, Deutsches Arzteblatt international.

[27]  M. Yaffe,et al.  Total cost-effectiveness of mammography screening strategies. , 2015, Health reports.

[28]  Karla Kerlikowske,et al.  Prevalence of mammographically dense breasts in the United States. , 2014, Journal of the National Cancer Institute.

[29]  J. Wardle,et al.  A survey study of women's responses to information about overdiagnosis in breast cancer screening in Britain , 2014, British Journal of Cancer.

[30]  Angela Fagerlin,et al.  Development and evaluation of a decision aid on mammography screening for women 75 years and older. , 2014, JAMA internal medicine.

[31]  T. To,et al.  Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: randomised screening trial , 2014, BMJ : British Medical Journal.

[32]  Thomas Agoritsas,et al.  How to use a subgroup analysis: users' guide to the medical literature. , 2014, JAMA.

[33]  Gerald Gartlehner,et al.  [GRADE guidelines 15: going from evidence to recommendation - determinants of a recommendation's direction and strength]. , 2014, Zeitschrift fur Evidenz, Fortbildung und Qualitat im Gesundheitswesen.

[34]  J. Thalabard,et al.  Overdiagnosis of breast cancer in the Norwegian Breast Cancer Screening Program estimated by the Norwegian Women and Cancer cohort study , 2013, BMC Cancer.

[35]  J. Hanley,et al.  Measuring the Mortality Impact of Breast Cancer Screening , 2013, Canadian Journal of Public Health.

[36]  J. Wardle,et al.  Women's responses to information about overdiagnosis in the UK breast cancer screening programme: a qualitative study , 2013, BMJ Open.

[37]  I. Vejborg,et al.  Overdiagnosis in screening mammography in Denmark: population based cohort study , 2013, BMJ : British Medical Journal.

[38]  L. Irwig,et al.  Women’s views on overdiagnosis in breast cancer screening: a qualitative study , 2013, BMJ.

[39]  D. Altman,et al.  The benefits and harms of breast cancer screening: an independent review , 2012, British Journal of Cancer.

[40]  L. Tabár,et al.  Long‐term incidence of breast cancer by trial arm in one county of the Swedish Two‐County Trial of mammographic screening , 2012, Cancer.

[41]  Håkan Jonsson,et al.  The Impact of Mammographic Screening on Breast Cancer Mortality in Europe: A Review of Observational Studies , 2012, Journal of medical screening.

[42]  Karla Kerlikowske,et al.  Relationship between mammographic density and breast cancer death in the Breast Cancer Surveillance Consortium. , 2012, Journal of the National Cancer Institute.

[43]  R. Thomson,et al.  Shared Decision Making: A Model for Clinical Practice , 2012, Journal of General Internal Medicine.

[44]  M. Barry,et al.  Shared decision making--pinnacle of patient-centered care. , 2012, The New England journal of medicine.

[45]  S. Duffy,et al.  Overdiagnosis in the population-based service screening programme with mammography for women aged 40 to 49 years in Sweden , 2012, Journal of medical screening.

[46]  D. Miglioretti,et al.  Risk Factors for Breast Cancer for Women Aged 40 to 49 Years A Systematic Review and Meta-analysis , 2012 .

[47]  Martin Fortin,et al.  Canadian Task Force on Preventive Health Care , 2012 .

[48]  Gerald Gartlehner,et al.  [GRADE guidelines: 7. Rating the quality of evidence - inconsistency]. , 2012, Zeitschrift fur Evidenz, Fortbildung und Qualitat im Gesundheitswesen.

[49]  Balancing harms and benefits of service mammography screening programs: a cohort study , 2012, Breast Cancer Research.

[50]  Gordon H Guyatt,et al.  GRADE guidelines: 7. Rating the quality of evidence--inconsistency. , 2011, Journal of clinical epidemiology.

[51]  Marcello Tonelli,et al.  Recommendations on screening for breast cancer in average-risk women aged 40–74 years , 2011, Canadian Medical Association Journal.

[52]  Ellen Warner,et al.  Clinical practice. Breast-cancer screening. , 2011, The New England journal of medicine.

[53]  L. Tabár,et al.  Swedish two-county trial: impact of mammographic screening on breast cancer mortality during 3 decades. , 2011, Radiology.

[54]  Kirsten Howard,et al.  Helping women make choices about mammography screening: an online randomized trial of a decision aid for 40-year-old women. , 2010, Patient education and counseling.

[55]  Montserrat Garcia-Closas,et al.  Genetic susceptibility to breast cancer , 2010, Molecular oncology.

[56]  S. Fletcher,et al.  Informed decision making before initiating screening mammography: does it occur and does it make a difference? , 2008, Health expectations : an international journal of public participation in health care and health policy.

[57]  R. Mcgee,et al.  Making policy decisions about population screening for breast cancer: the role of citizens' deliberation. , 2008, Health policy.

[58]  Kirsten Howard,et al.  Informed choice in mammography screening: a randomized trial of a decision aid for 70-year-old women. , 2007, Archives of internal medicine.

[59]  N. Boyd,et al.  Mammographic density and the risk and detection of breast cancer. , 2007, The New England journal of medicine.

[60]  L. Kinsinger,et al.  A randomized trial of three videos that differ in the framing of information about mammography in women 40 to 49 years old , 2003, Journal of General Internal Medicine.

[61]  Michael Waller,et al.  Effect of mammographic screening from age 40 years on breast cancer mortality at 10 years' follow-up: a randomised controlled trial , 2006, The Lancet.

[62]  S. Cha,et al.  Efficacy of a simple, low-cost educational intervention in improving knowledge about risks and benefits of screening mammography. , 2006, Mayo Clinic proceedings.

[63]  V. McCormack,et al.  Breast Density and Parenchymal Patterns as Markers of Breast Cancer Risk: A Meta-analysis , 2006, Cancer Epidemiology Biomarkers & Prevention.

[64]  Ingvar Andersson,et al.  Rate of over-diagnosis of breast cancer 15 years after end of Malmö mammographic screening trial: follow-up study , 2006, BMJ : British Medical Journal.

[65]  H. Yasunaga,et al.  Women’s Anxieties Caused by False Positives in Mammography Screening: A Contingent Valuation Survey , 2006, Breast Cancer Research and Treatment.

[66]  J. Ward,et al.  Reconciling population benefits and women's individual autonomy in mammographic screening: in‐depth interviews to explore women's views about ‘informed choice’ , 2005, Australian and New Zealand journal of public health.

[67]  K. Offit,et al.  Hereditary cancer predisposition syndromes. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[68]  L. Rutqvist,et al.  Followup after 11 years – update of mortality results in the Stockholm mammographic screening trial , 1997, Breast Cancer Research and Treatment.

[69]  J. Hopper,et al.  Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. , 2003, American journal of human genetics.

[70]  V. Semiglazov,et al.  [Results of a prospective randomized investigation [Russia (St.Petersburg)/WHO] to evaluate the significance of self-examination for the early detection of breast cancer]. , 2003, Voprosy onkologii.

[71]  Roberta M Ray,et al.  Randomized trial of breast self-examination in Shanghai: final results. , 2002, Journal of the National Cancer Institute.

[72]  T. To,et al.  The Canadian National Breast Screening Study-1: Breast Cancer Mortality after 11 to 16 Years of Follow-up: A Randomized Screening Trial of Mammography in Women Age 40 to 49 Years , 2002, Annals of Internal Medicine.

[73]  Ingvar Andersson,et al.  Long-term effects of mammography screening: updated overview of the Swedish randomised trials , 2002, The Lancet.

[74]  H. Welch,et al.  US women's attitudes to false positive mammography results and detection of ductal carcinoma in situ: cross sectional survey. , 2000, BMJ.

[75]  D. Gyrd-Hansen.  COST-BENEFIT ANALYSIS OF MAMMOGRAPHY SCREENING IN DENMARK BASED ON DISCRETE RANKING DATA , 2000, International Journal of Technology Assessment in Health Care.

[76]  A Gafni,et al.  A cross-cultural consumer-based decision aid for screening mammography. , 2000, Preventive medicine.

[77]  C J Baines,et al.  The Gothenburg breast screening trial , 1997, Cancer.

[78]  L. Tabár,et al.  Efficacy of breast cancer screening by age. New results swedish two‐county trial , 1995, Cancer.

[79]  A. Miller,et al.  Canadian National Breast Screening Study: 1. Breast cancer detection and death rates among women aged 40 to 49 years. , 1992, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[80]  A. Miller,et al.  Canadian National Breast Screening Study: 2. Breast cancer detection and death rates among women aged 50 to 59 years. , 1992, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[81]  T. Landberg,et al.  Mammographic screening and mortality from breast cancer: the Malmö mammographic screening trial. , 1988, BMJ.

[82]  V. Saliba,et al.  Public Health in England. , 1988, Public health.

[83]  S. Shapiro,et al.  Ten- to fourteen-year effect of screening on breast cancer mortality. , 1982, Journal of the National Cancer Institute.

[84]  C. Fox,et al.  Breast-cancer screening. , 1979, Lancet.